KRRO
Korro Bio, Inc.
10.20$
-4.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +12.3% | -42.7% | -25.3% | +18.5% | -100.0% | – | – | |
| – | +90.5% | -58.5% | -0.7% | +20.0% | -267.3% | – | – | – | – | -41.4% | – | – | |
| – | – | – | – | – | – | +12.3% | -42.7% | -25.3% | -41.0% | -159.1% | – | – | |
| – | +10.1% | -12.0% | +26.3% | -6.9% | +6.3% | +16.4% | +6.5% | -34.3% | -20.5% | +17.9% | +4.9% | – | |
| – | +95.5% | -31.5% | -11.5% | +5.4% | +30.0% | -6.2% | -12.4% | -5.1% | -4.9% | +20.9% | -12.9% | – | |
| – | +40.4% | -20.2% | +12.5% | -3.5% | +8.7% | +8.9% | +4.0% | -29.1% | -18.7% | +23.7% | -1.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +240.0% | +76.5% | -130.0% | – | – | – | – | – | -85.1% | +13.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.